ResMed revenue surges on ventilator push

ResMed revenue surges on ventilator push

Pivoting from sleep disorder machines to ventilator production for COVID-19 victims has boosted quarterly revenue at ASX-listed health firm ResMed. The US-based respiratory health company increased revenue 16 per cent to $US769.5 million ($A1.19 billion) for the three...